JP MORGAN/PUT/FRESENIUS/28/0.1/20.12.24 Share Price

Warrant

DE000JL2EFK1

Market Closed - Börse Stuttgart 08:33:52 05/07/2024 BST
0.15 EUR -6.25% Intraday chart for JP MORGAN/PUT/FRESENIUS/28/0.1/20.12.24
Current month-21.05%
1 month-6.25%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.15 -6.25%
04/07/24 0.16 0.00%
03/07/24 0.16 -15.79%
02/07/24 0.19 +5.56%
01/07/24 0.18 -5.26%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:33 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer J.P. Morgan
WKN JL2EFK
ISINDE000JL2EFK1
Date issued 10/05/2023
Strike 28
Maturity 20/12/2024 (168 Days)
Parity 10 : 1
Emission price 0.49
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.57
Lowest since issue 0.13
Delta-0.35x
Omega 6.635
Premium9.11x
Gearing18.77x
Moneyness 0.9622
Difference Strike -1.1
Difference Strike %-3.93%
Spread 0.01
Spread %6.25%
Theoretical value 0.1550
Implied Volatility 29.33 %
Total Loss Probability 57.04 %
Intrinsic value 0.000000
Present value 0.1550
Break even 26.45 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.1 EUR
Average target price
37.26 EUR
Spread / Average Target
+28.03%
Consensus